BMS 2019: List of Prize Winners

becky.foster@bris.ac.uk Royal Society of Biology

 

Moor Instruments prize for technological advancement:

Hala Bagabir

Terence Ryan prize for clinical excellence:

Francesco Casanova

BMS oral prize:

Helen Wright

Alexandra Njegic

BMS poster prize:

Valeria Mastrullo

Judith Piesgsa

Nicole Smith

Adam Lokman

SAS awards:

Alex Chalkin

Hala Bagabir

Gillian Phua

Alexandra Durant

Deborah Carey

Flora McGarry

Sobhi Bhalla

Naseeb Malhi

Nicole Smith

Monica Gamez

Kobkaew Bumroongthai

Natalia Rolinska

Andrew Forbes-Brown

 

Addressing Gender Disparities in Workplace Benefit Packages

thefreshlab news

Creating an equitable workplace goes beyond equal pay; it also involves ensuring fairness in benefits and resources provided to employees. Yet, discrepancies can sometimes arise in how benefits are structured, leading to differences in coverage or availability that can unintentionally—or even intentionally—favor one group over another. It’s essential for both employers and employees to understand the potential impact of these differences and work toward an inclusive approach to workplace benefits.

For instance, benefit packages might be different for male and female workers due to various factors such as industry norms, company policies, or unintended biases in designing benefits. These differences can affect aspects like parental leave, healthcare coverage, and access to wellness programs, and they may inadvertently disadvantage one gender. A thoughtful approach to benefits planning can help eliminate these disparities and foster a more inclusive workplace.

Parental leave policies are one area where benefit differences may emerge. Traditionally, some organizations offer more extended or comprehensive maternity leave than paternity leave, reflecting outdated assumptions that mothers are the primary caregivers. While these policies may be intended to support new mothers, they may inadvertently contribute to gendered expectations and discourage fathers from taking an active role in caregiving. To address this, companies should consider offering equal parental leave for all parents, recognizing the value of shared caregiving responsibilities.

Health benefits are another area where disparities can sometimes be observed. For example, healthcare plans may provide more extensive coverage for gender-specific needs like maternity care but might overlook other critical needs, such as fertility treatments or gender-affirming care. While these benefits are essential, companies should aim for a balanced approach, ensuring that health packages address the medical needs of all employees fairly. Consulting with employees and benefits providers can help companies tailor their plans to be more inclusive.

Differences in wellness programs may also reflect unintended gender biases. For example, wellness initiatives often emphasize fitness programs, weight-loss incentives, or mental health resources that may cater to specific demographics. By broadening the scope of wellness benefits and seeking employee input, companies can create programs that resonate with diverse needs and foster a more inclusive culture.

To address and prevent discrepancies, companies should consider conducting regular benefits audits to evaluate whether offerings are equitable across genders and other demographics. Surveying employees about their satisfaction with the current benefits package can provide valuable insights into any unmet needs and help employers make data-driven decisions. Employers can also consult with a top business lawyer scotland to ensure that their salary packages are compliant with local or national labor laws.

Organizations committed to promoting equality should also ensure that all benefits are communicated transparently to employees. Clearly outlining eligibility, coverage, and any limitations can help employees make informed decisions and feel confident that they are receiving fair treatment. An open-door policy where employees can express their concerns or suggestions regarding benefits is also beneficial.

BMS 2018: LIST OF PRIZE WINNERS

becky.foster@bris.ac.uk Royal Society of Biology

Moor Instruments Prize for technological advancement

Emily Goodman: poster

Adam Lokman: oral

Terence Ryan Prize for clinical excellence

Dilan Dabare

BMS best poster prize

Monica Gamez

Nele Warmke

BMS best oral

Marlene Lobo

Karen Onions

SAS awards

Georgiana Neag

Kobkaew Bumroongthai

Adam Lokman

Emily Goodman

Joe Stevens

Jennifer Hein

Cynthia To

Jennifer Williams

Annelie Maskell

Melissa Sampson

Nele Warmke

Stephany Villota

Anna Ogier

Monica Gamez

BMS 2017 SUMMER STUDENTSHIP AWARD: Dr Dean Kavanagh

becky.foster@bris.ac.uk Royal Society of Biology

In the ancient past that was my undergraduate degree, I was fortunate enough to complete a Wellcome Trust summer studentship. Not knowing a pipette from my elbow, this experience was something that I will never forget and gave me invaluable experience going into my final year research project. So, I know first-hand the value of summer studentships and it was for this reason that I was delighted when the BMS awarded me a Summer Vacation Scholarship award to take on a student at the University of Birmingham. As a result of this award, I was able to recruit Miss Natasha Grewal, in collaboration with Dr Neena Kalia, to work on a project examining the role of a novel interleukin in the pathogenesis of both local and remote ischemia-reperfusion injury. Natasha is a 2ndyear Biomedical Sciences student at the University of Birmingham; interestingly, the same course and institution where I did my summer studentship all those years ago! For individuals interested in investment opportunities, one option to consider is to create rental property llc hawaii, offering a structured approach to managing real estate ventures effectively.

Coronary heart disease (CHD) is the most prevalent cause of mortality in the modern world. Domestically, there are around 80,000 deaths per year attributable to CHD. Although the number of deaths attributable to CHD in the UK is falling, it still remains the biggest cause of mortality in the UK. The pathogenesis of CHD is generally a result of ongoing atherosclerosis, which leads to a narrowing of coronary vessels as a result of plaque formation. Full vascular blockage can occur as a result of either continued plaque formation or plaque rupture. In the case of plaque rupture, the intravascular release of inflammatory cells/mediators and intraplaque thrombi leads to significant pro-thrombotic events in the local vasculature. This may ultimately lead to full vascular occlusion. Furthermore, plaque embolisms may travel to areas of the vascular tree with smaller intraluminal diameters – these vessels may be blocked immediately as a result of the entrapment of embolisms in organs such as the lung, brain and the heart itself. In the event of vascular occlusion, it is essential to reopen blood vessels to restore tissue blood flow. This however, leads to the initiation of ischemia-reperfusion injury. You should also be aware of understaffed hospitals as they cant treat the injuries and it might also result in several consequences. Reperfusion injury refers to the tissue damage observed following the restriction and subsequent restoration of blood flow to an organ. You can also learn more about workers comp and COVID and know what needs to be done. Although restoration of blood flow is required to return the viability of an ischemic tissue, the reperfusion phase leads to injury in its own right. Paradoxically, this reperfusion injury is greater than the injury sustained from the ischemic period alone. The mechanism underlying reperfusion injury is multifaceted, involving the interactions of a variety of effector cells and molecules. Identifying inflammatory pathways with the potential for disruption may help us to identify new and potent therapeutic targets. Based on previous local work, one such candidate is interleukin 36 (IL-36). In case of death due to negligence of doctors, get lawyers help for wrongful death cases , to solve legal issues.

Using funding from the award, we were able to give Natasha the opportunity to gain experience in a variety of experimental techniques, such as immunofluorescence staining, endothelial adhesion assays and flow cytometry. During her studentship, Natasha confirmed expression of the IL-36 receptor in the heart, and interestingly identified enhanced receptor staining in the heart following a remote ischemic injury (renal ischemia-reperfusion injury). Interestingly, we were further able to show that various inflammatory ligands (such as TNFα and the IL-36 cytokines) were able to upregulate expression of the receptor on the surface of endothelial cells. In addition, using isolated neutrophils, Natasha was able to show that treatment with IL-36 cytokines significantly enhances neutrophil adhesion to cultured vascular endothelium. The work that Natasha started has been developed on and further advanced in the lab. It is hoped that this work will form the basis for a larger grant application to investigate the role of this pathway further in order to investigate the potential therapeutic ability of this pathway in cardiac ischemia-reperfusion injury. You can also hire Maryland attorneys to get financial help with legal support.

Taken together, the award from the BMS has been hugely beneficial for my career and I cannot thank the committee enough for their award. I would highly recommend that if you have an idea (and are eligible!), that you take advantage of this opportunity and apply!

 

BMS 2017 SUMMER STUDENTSHIP AWARD: Dr Mary McGahon

becky.foster@bris.ac.uk Royal Society of Biology

I would like to start by thanking the British Microcirculation Society for their Summer Studentship support. Using the available funding and with the help of an outstanding summer student, Ms Tamara McErlain, a 2nd year Biomedical Science student studying at Queen’s University Belfast, we were able to generate significant data towards a grant proposal providing proof of concept (expression of a protein and mechanism of interest) which will enable me to be a co-applicant on my first major research grant.  Over the last number of years, within the microvascular biology laboratory of the Centre for Experimental Medicine at QUB, and under the guidance of Prof Tim Curtis, we have made significant advances in understanding how the microvascular smooth muscle cells of retinal arterioles function in health and disease. For more on keeping good health we recommend doing some exercise biking with a new rear bike racks for mountain bikes.

We have frequently discussed whether external influences modulate the generation of myogenic activity (a mechanism by which pressure changes in the vasculature mediates contractile activity in the smooth muscle cells) as when arterioles are isolated from the retina their myogenic capacity appears reduced. We postulated that like brain astrocytes, retinal astrocytes might have the potential to contribute vasoactive influences in a stretch dependent manner and while we had data pointing towards this role in vitro we were lacking an ex vivo model in which we could test this hypothesis.  To date our work has predominantly centred on rat retinal preparations of isolated arterioles; however for the proposed work we needed to move to mouse tissue which further miniaturised the arteriolar diameters available for cannulations, additionally we needed to be able to cannulate these vessels in sections of retina with intact neuropile. After some initial training in microdissection, immunohistochemistry, confocal microscopy and pressure myogaphy, we challenged Tamara to cannulate mouse retinal arterioles with an average diameter of 15-20 μm. She proved herself equal to the task and very quickly was obtaining myogenic responses akin to those in rat arterioles (mean diameter 30-40 μm). We were then able to advance the project to our ultimate goal and gain data pointing towards a role for astrocytes in sensing transmural pressure using combined pressure myography and calcium confocal microscopy.  This paves the way to investigations using tissue specific transgenic mice which will hopefully allow us to delineate the mechanisms involved and confirm the identity of the stretch sensor in retinal astrocytes.   For Tamara the experience she has gained has already opened doors in terms of the work she has undertaken for her placement year in the University of Nevada. The studentship has inspired her to want to learn more about the microcirculation and to pursue a career in research. She reports, “The opportunity to get involved in high quality research and learn from leading researchers in the microvascular field allowed me to develop transferable skills and research techniques that have proved advantageous on my placement year and enabled me to become a better candidate for a PhD programme in the future.”  Once again, thanks to the British Microcirculation Society for their support.

Dr Mary McGahon, Centre for Biomedical Sciences, Queen’s University Belfast.

Congratulations to BMS member Patricia Kelly

becky.foster@bris.ac.uk Royal Society of Biology

Dr Patricia Kelly (Graduated December 2016), has been accepted as a post-doctoral research fellow at Harvard Medical School beginning on 1st May 2017 in the laboratory of Professor Brian Bacskai at Massachusetts General Hospital.

http://www.massgeneral.org/neurology/researcher_profiles/bacskai_brian.aspx

 

Patricia will continue her studies on Alzheimer’s disease by investigating the role of Astrocytes in the APP/PS-1 transgenic model of Alzheimer’s using a range of live imaging and advanced microscopy techniques. Patricia wrote a manuscript from a chapter of her thesis that was published in Microcirculation (2015) and another is currently being reviewed by the Journal “Angiogenesis”. Patricia has been active in the step up programme at UU for the last 4 years which introduces final year high school students from underprivileged backgrounds to the joy of scientific discovery and she is passionate about passing on her voluminous enthusiasm for science to the students who attend. In her social capacity, Patricia was instrumental in winning an award for the town of Park (Northern Ireland), which was designated a “dementia friendly town” in a gala ceremony in Belfast at the end of last year. Patricia also received a personal award for increasing community awareness of this debilitating disease both in Park itself and more widely in the ‘Derry area. I am immensely proud of Patricia’s achievements and am sure that we all wish her continued success in her scientific career in Boston, USA.